Publications by authors named "S Schlotter"
Epstein-Barr virus (EBV) is a ubiquitous herpes virus associated with various cancers. EBV establishes latency with life-long persistence in memory B-cells and can reactivate lytic infection placing immunocompromised individuals at risk for EBV-driven lymphoproliferative disorders (EBV-LPD). Despite the ubiquity of EBV, only a small percentage of immunocompromised patients (~20%) develop EBV-LPD.
View Article and Find Full Text PDFArticle Synopsis
- This study compares immune system recovery in HIV-positive and HIV-negative patients after undergoing autologous hematopoietic cell transplant (AHCT) for lymphoma, evaluating their immune responses at multiple time points.
- Principal component analysis revealed that both groups showed distinct immune cell compositions compared to healthy controls, but their profiles improved over time, indicating a trend towards normalcy.
- Key findings include that HIV-positive recipients had higher levels of certain activated T cells but lower counts of B cells and natural killer (NK) cells, suggesting specific immune challenges that could inform treatment strategies for these patients.
Background: Regular participation in exercise is important for people with cystic fibrosis (CF). Therefore, we implemented a personalized, web-based exercise intervention over the course of one year for people with CF. The aims were to investigate the feasibility of the intervention and to evaluate changes in exercise participation, lung function, and exercise capacity.
View Article and Find Full Text PDFEpstein-Barr virus (EBV) is a human herpes virus that infects over 90% of the world's population and is linked to development of cancer. In immune-competent individuals, EBV infection is mitigated by a highly efficient virus-specific memory T-cell response. Risk of EBV-driven cancers increases with immune suppression (IS).
View Article and Find Full Text PDFNon-Hodgkin lymphoma (NHL) is a heterogeneous group of blood cancers arising in lymphoid tissues that commonly effects both humans and dogs. Protein arginine methyltransferase 5 (PRMT5), an enzyme that catalyzes the symmetric di-methylation of arginine residues, is frequently overexpressed and dysregulated in both human solid and hematologic malignancies. In human lymphoma, PRMT5 is a known driver of malignant transformation and oncogenesis, however, the expression and role of PRMT5 in canine lymphoma has not been explored.
View Article and Find Full Text PDF